EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis

Sang Jun Yoon, Jeong Seok Yu, Byeong Hyun Min, Haripriya Gupta, Sung-Min Won, Hee Jin Park, Sang Hak Han, Byung-Yong Kim, Kyung Hwan Kim, Byoung Kook Kim, Hyun Chae Joung, Tae-Sik Park und 3 weitere

Frontiers in Microbiology · 01.03.2023 · 14

DOI: 10.3389/fmicb.2023.1129904 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 01.03.2023. Verfasst von Sang Jun Yoon und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Liver and Digestive Disease, Hallym University, Chuncheon, Republic of Korea. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Trade, Industry and Energy, Ministry of SMEs and Startups, Ministry of Agriculture, Food and Rural Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emerging evidences about gut-microbial modulation have been accumulated in the treatment of nonalcoholic fatty liver disease (NAFLD). We evaluated the effect of Bifidobacterium breve and Bifidobacterium longum on the NAFLD pathology and explore the molecular mechanisms based on multi-omics approaches. Human stool analysis [healthy subjects ( n = 25) and NAFLD patients ( n = 32)] was performed to select NAFLD-associated microbiota. Six-week-old male C57BL/6 J mice were fed a normal chow diet (NC), Western diet (WD), and WD with B. breve (BB) or B. longum (BL; 109 CFU/g) for 8 weeks. Liver/body weight ratio, histopathology, serum/tool analysis, 16S rRNA-sequencing, and metabolites were examined and compared. The BB and BL groups showed improved liver histology and function based on liver/body ratios (WD 7.07 ± 0.75, BB 5.27 ± 0.47, and BL 4.86 ± 0.57) and NAFLD activity scores (WD 5.00 ± 0.10, BB 1.89 ± 1.45, and BL 1.90 ± 0.99; p < 0.05). Strain treatment showed ameliorative effects on gut barrier function. Metagenomic analysis showed treatment-specific changes in taxonomic composition. The community was mainly characterized by the significantly higher composition of the Bacteroidetes phylum among the NC and probiotic-feeding groups. Similarly, the gut metabolome was modulated by probiotics treatment. In particular, short-chain fatty acids and tryptophan metabolites were reverted to normal levels by probiotics, whereas bile acids were partially normalized to those of the NC group. The analysis of gene expression related to lipid and glucose metabolism as well as the immune response indicated the coordinative regulation of β-oxidation, lipogenesis, and systemic inflammation by probiotic treatment. BB and BL attenuate NAFLD by improving microbiome-associated factors of the gut-liver axis.

Schlagwörter

Stichwörter der Autor:innen

gut microbiotagut-liver axismetagenomicsnonalcoholic fatty liver diseaseprobiotics

Autor:innen und Institutionen

  • Institute for Liver and Digestive Disease, Hallym University, Chuncheon, Republic of Korea.
  • Department of Agricultural Biotechnology, Center for Food and Bioconvergence, Research Institute of Agricultural and Life Sciences, Seoul National University, Seoul, Republic of Korea.
  • Department of Pathology, Hallym University College of Medicine, Chuncheon, Republic of Korea.
  • Chong Kun Dang Healthcare Institute, Seoul, Republic of Korea.
  • Chong Kun Dang Bio Research Institute, Gyeonggi-do, Republic of Korea.
  • Department of Life Science, Gachon University, Sungnam, Republic of Korea.

Förderung

  • Ministry of Trade, Industry and Energy
  • Ministry of SMEs and Startups
  • Ministry of Agriculture, Food and Rural Affairs

Zitieren

APA

Yoon, S. J., Yu, J. S., Min, B. H., Gupta, H., Won, S. M., Park, H. J., Han, S. H., Kim, B. Y., Kim, K. H., Kim, B. K., Joung, H. C., Park, T. S., Ham, Y. L., Lee, D. Y., & Suk, K. T. (2023). Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1129904

Vancouver

Yoon SJ, Yu JS, Min BH, Gupta H, Won SM, Park HJ, et al. Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1129904

BibTeX
@article{Yoon2023,
  author = {Yoon, Sang Jun and Yu, Jeong Seok and Min, Byeong Hyun and Gupta, Haripriya and Won, Sung-Min and Park, Hee Jin and Han, Sang Hak and Kim, Byung-Yong and Kim, Kyung Hwan and Kim, Byoung Kook and Joung, Hyun Chae and Park, Tae-Sik and Ham, Young Lim and Lee, Do Yup and Suk, Ki Tae},
  title = {Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis},
  journal = {Frontiers in Microbiology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fmicb.2023.1129904}
}
Kostenlos starten →